Anthropic Acquires Biotech Startup Coefficient Bio in $400 Million Deal
Anthropic has purchased AI-focused biotech startup Coefficient Bio for approximately $400 million, adding the ten-person team to its health and life sciences division.
Key Points
- Anthropic acquires Coefficient Bio for approximately $400 million
- Coefficient Bio team of about 10 people will join Anthropic's health and life science division
- The startup was using AI to improve drug discovery and biological research efficiency
- Acquisition follows Anthropic's October launch of Claude for Life Sciences tool
Full Details
Anthropic continues its expansion into healthcare and life sciences with the acquisition of Coefficient Bio, a biotech startup that was using artificial intelligence to streamline drug discovery and biological research. The deal, reportedly worth $400 million, brings around 10 researchers into Anthropic's health and life science team. This move follows Anthropic's October announcement of 'Claude for Life Sciences,' a tool designed to help scientific researchers make discoveries more efficiently. The acquisition represents a significant bet on AI-driven pharmaceutical research, an area where major tech companies are increasingly competing to develop tools that can accelerate the traditionally slow and expensive drug development process.
Why It Matters
This acquisition signals Anthropic's serious commitment to the healthcare and pharmaceutical AI market, potentially intensifying competition with other AI giants like Google DeepMind and Microsoft in the drug discovery space.
Get stories like this delivered daily
AI-curated news, personalized to your interests. Zero noise.
Start 7-Day Free Trial →More in Technology & Startups
SpaceX IPO to Reshape Space Economy, Enable Data Centers in Space
SpaceX's upcoming IPO will join other major space companies in going public, with Elon Musk planning to build data centers in space to support AI growth following SpaceX's merger with xAI earlier this year.
AI-Driven Corporate Earnings Signal China's Strengthening Economic Momentum
Chinese listed companies are reporting strong 2025 results, with AI chip maker Cambricon posting its first annual profit of RMB 2.06 billion and Foxconn Industrial Internet achieving 50% revenue and profit growth, both driven by AI demand.
OpenAI Announces Major Executive Reshuffle Amid IPO Preparations
OpenAI has announced significant leadership changes, moving COO Brad Lightcap to a special projects role reporting to CEO Sam Altman, while CMO Kate Rouch steps down for cancer recovery and AGI division head Fidji Simo takes medical leave.
Scientists Unveil Leather Handbag Derived from Dinosaur DNA
Researchers have created a leather handbag using DNA extracted from dinosaur remains, representing a breakthrough in biotechnology and sustainable materials.